Neoadjuvant Nivolumab with or without Ipilimumab for Cisplatin-Ineligible Patients with Muscle-Invasive Bladder Cancer
- Brendan J. Guercio
- , Eugene J. Pietzak
- , Vignesh Ravichandran
- , Jie-Fu Chen
- , Ronak H. Shah
- , Vanessa Peters
- , Ashley M. Regazzi
- , Scot A. Niglio
- , David H. Aggen
- , Samuel A. Funt
- , Timothy F. Donahue
- , Alvin C. Goh
- , Eugene K. Cha
- , Phillip Wong
- , Allison L. Richards
- , Cassidy C. Cobbs
- , S. Machele Donat
- , Guido Dalbagni
- , Bernard H. Bochner
- , Gopa Iyer
- , Mark T.A. Donoghue
- , Irina Ostrovnaya
- , Hikmat A. Al-Ahmadie
- , Jonathan E. Rosenberg
- , Min Yuen Teo
No endorsements
This article has not been endorsed yet.
Like this work?
Let others know. Sign in to add your endorsement.